Of the 1,433 respondents who completed the baseline survey, 36% (510/1,433) reported that they would ''definitely not'' take pH1N1 vaccination during the winter flu season; 36% (521/1,433) reported being ''very unlikely/unlikely'' to take it; 19% (278/ 1,433) reported their pH1N1 vaccination likelihood as ''evens'' (50:50/equal likelihood); and only 8% (119/1,433) reported vaccination likelihood as ''likely/very likely/certain''. Within the subset of 896/1,433 respondents who completed both baseline and follow-up surveys, 7% (67/896) had reported at baseline that they would be ''likely/very likely/certain'' to receive pH1N1 vaccination. However, in the follow-up survey, only 7/896 (0.8%) respondents reported having received pH1N1 vaccination in the intervening period, 4 of whom had reported being ''likely/very likely/certain'' to receive pH1N1 vaccination at baseline.